Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2023
2024
2023 - 2024
Zafrens is a company developing a massively parallel drug discovery platform.
2022
2024
2022 - 2024
Prime Movers Lab invests in breakthrough scientific startups founded by the world's prime movers – the inventors who transform billions of lives across energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture. PML is actively investing out of Fund 3, an early stage fund, and has $1.2B under management. We offer Prime Movers comprehensive resources and integrated coaching to support the transformation of world-class technical experts into extraordinary executives. Our team has developed in-depth academic scientific research, commercialized novel intellectual property, scaled significant enterprises, and mentored renowned scientists on their entrepreneurial journey.
2022 - 2022
2023
2023
LyGenesis is a clinical-stage startup pioneering the use of lymph nodes as living bioreactors to transform transplant medicine and expand the field of cell therapy for millions of patients.
2023
2023
Iridia is storing the world of data in physical form using nature's building block, DNA.
2023
Morphoceuticals is developing therapeutics modulating the “bio-electrome” to regrow human limbs, repair injuries, and treat rare congenital diseases and malformations based on the research of Drs. Michael Levin and David Kaplan.
2022
2022
2023 - 2024
2023 - 2024
Gilgamesh is a clinical-stage company developing safer, more beneficial molecules at the forefront of psychedelic medicine.
2023 - 2024
2023 - 2024
2023 - 2024
2023 - 2024
Dimension inx manufactures the substrates for life for use as tissue therapeutics, including 3D printed bone grafts, soft tissue replacements, and injectable bioscaffolds.
2022 - 2024
2022 - 2024